Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Cost of RevenueEBIATGross ProfitReceivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Nexalin Technology (NXL) Cost of Revenue (2021 - 2026)

Nexalin Technology has reported Cost of Revenue over the past 5 years, most recently at $21029.0 for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 180.54% year-over-year to $21029.0; the TTM value through Dec 2025 reached $61373.0, up 67.72%, while the annual FY2025 figure was $61373.0, 67.72% up from the prior year.
  • Cost of Revenue for Q4 2025 was $21029.0 at Nexalin Technology, up from $3948.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $187298.0 in Q3 2022 and troughed at -$1006.0 in Q4 2021.
  • A 5-year average of $27509.2 and a median of $9231.0 in 2021 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 1912.66% in 2022 and later crashed 97.88% in 2023.
  • Year by year, Cost of Revenue stood at -$1006.0 in 2021, then skyrocketed by 782.6% to $6867.0 in 2022, then fell by 23.82% to $5231.0 in 2023, then surged by 43.3% to $7496.0 in 2024, then surged by 180.54% to $21029.0 in 2025.
  • Business Quant data shows Cost of Revenue for NXL at $21029.0 in Q4 2025, $3948.0 in Q3 2025, and $22838.0 in Q2 2025.